NCT06768879

Brief Summary

Uterine fibroids are a major cause of illness in women of a reproductive age. There are many factors involved in the growth and reduction of these common tumors. The most likely cause of fibroids is their effect on a woman's menstrual cycle. For accurate diagnosis numerous diagnostic markers on ultrasound are present which increases the efficacy of ultrasound to diagnose uterine fibroids.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
97

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 25, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 8, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 18, 2024

Completed
23 days until next milestone

First Posted

Study publicly available on registry

January 10, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

January 10, 2025

Status Verified

January 1, 2025

Enrollment Period

6 months

First QC Date

December 18, 2024

Last Update Submit

January 6, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • two-dimensional ultrasound scan (GE Loginq P7 convex probe.3.5-5MHz)

    On ultrasound using (GE Loginq P7 convex probe.3.5-5MHz), a uterine fibroid is classically characterized as a solid, round, well-defined, hypoechoic, heterogeneous lesion within the myometrium, often showing acoustic shadowing at the edge of the lesion

    12 Months

Interventions

UltrasoundRADIATION

To evaluate the different location of uterine fibroids in patient with disturbed menstrual cycle on ultrasound

Eligibility Criteria

Age15 Years - 35 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsIrregular Menstrul Cycle
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Aim is to check Irregular Menstrul Cycle with Sonographic Evaluation Of Uterine Fibroids

You may qualify if:

  • Patient with Pelvic pain
  • Patient with Abdominal pain
  • Patient with heavy bleeding
  • Patient with Dysmenorrhea
  • Polymenorrhea

You may not qualify if:

  • Patient with H/O Cystectomy
  • Patient with H/O cyst

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

THQ hospital Pattoki/ Siddique medical center Pattoki

Pattoki, Punjab Province, Pakistan

Location

MeSH Terms

Conditions

Menstruation Disturbances

Interventions

High-Energy Shock Waves

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Ultrasonic WavesSoundRadiation, NonionizingRadiationPhysical Phenomena

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 18, 2024

First Posted

January 10, 2025

Study Start

February 25, 2024

Primary Completion

August 8, 2024

Study Completion

March 1, 2025

Last Updated

January 10, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations